Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome
Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome
SAGA Metals Reports Assays from R-0021 to R-0023 with Intercepts Including 53.18% Fe?O?, 7.08% TiO?, 0.414% V?O? from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
Kobo Resources Intersects Strong Gold Results Across All Three Zones at Kossou, Including 7.0 m at 5.06 g/t Au at the Road Cut Zone
CHARBONE annonce une entente de conditions avec RiverFort pour un pret convertible de 10 millions de dollars
